title: Reply to E. C. Smyth et al.
authors: Academic Medical Center of Amsterdam, Amsterdam, the Netherlands m.c.hulshof@amc.uva.nl.
authors: Maarten C C M
authors: MC
authors: Hulshof
authors: Academic Medical Center of Amsterdam, Amsterdam, the Netherlands.
authors: Vera
authors: V
authors: Oppedijk
authors: Erasmus Medical Center, Rotterdam, the Netherlands.
authors: Ate
authors: A
authors: van der Gaast
mesh_terms: D000230:Adenocarcinoma / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D004938:Esophageal Neoplasms / Q000628:therapy*; D016629:Esophagectomy; D004943:Esophagogastric Junction; D005260:Female; D005743:Gastrectomy / Q000009:adverse effects*; D006801:Humans; D008297:Male; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D013274:Stomach Neoplasms / Q000628:therapy*